Thrombospondins: From structure to therapeutics

Cellular and Molecular Life Sciences

Volumn 65, Issue 5, 2008, Pages 669-671

  Roberts, D D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Blood flow; Bone development; Cancer; Extracellular matrix; Hemostasis; Inherited disorders

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; CELL SURFACE RECEPTOR; NITRIC OXIDE; THROMBOSPONDIN 1;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; CARBOXY TERMINAL SEQUENCE; CELL MOTILITY; ENDOTHELIUM CELL; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; MUTATION; NONHUMAN; PROTEIN STRUCTURE; SHORT SURVEY;

ANIMALS; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; THROMBOSPONDINS;

EID: 40449141382     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7483-2     Document Type: Short Survey

References (13)

1. Lawler, J., Sunday, M., Thibert, V., Duquette, M., George, E. L., Rayburn, H. and Hynes, R. O. (1998) Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest. 101, 982-992.
2. Bagavandoss, P. and Wilks, J. W. (1990) Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 170, 867-872.
3. Good, D. J., Polverini, P. J., Rastinejad, F., Le, B. M., Lemons, R. S., Frazier, W. A. and Bouck, N. P. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624-6628.
4. Taraboletti, G., Roberts, D., Liotta, L. A. and Giavazzi, R. (1990) Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell. Biol. 111, 765-772.
5. Iruela-Arispe, M. L., Lombardo, M., Krutzsch, H. C., Lawler, J. and Roberts, D. D. (1999) Inhibition of angiogenesis by thrombspondin-1 is mediated by two independent regions within the type 1 repeats. Circulation 100, 1423-1431.
6. Lawler, J. and Detmar, M. (2004) Tumor progression: the effects of thrombospondin-1 and -2. Int. J. Biochem. Cell. Biol. 36, 1038-1045.
7. Dameron, K. M., Volpert, O. V., Tainsky, M. A. and Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584.
8. Janz, A., Sevignani, C., Kenyon, K., Ngo, C. V. and Thomas-Tikhonenko, A. (2000) Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA. Nucleic Acids Res. 28, 2268-2275.
9. Zabrenetzky, V., Harris, C. C., Steeg, P. S. and Roberts, D. D. (1994) Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int. J. Cancer 59, 191-195.
10. Markovic, S. N., Suman, V. J., Rao, R. A., Ingle, J. N., Kaur, J. S., Erickson, L. A., Pitot, H. C., Croghan, G. A., McWilliams, R. R., Merchan, J. et al. (2007) A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma. Am. J. Clin. Oncol. 30, 303-309.
11. Topol, E. J., McCarthy, J., Gabriel, S., Moliterno, D. J., Rogers, W. J., Newby, L. K., Freedman, M., Metivier, J., Cannata, R., O'Donnell, C. J. et al. (2001) Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 104, 2641-2644.
12. Moncada, S. and Higgs, E. A. (2006) The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 147 Suppl. 1, S193-S201.
13. Shiva, S., Huang, Z., Grubina, R., Sun, J., Ringwood, L. A., MacArthur, P. H., Xu, X., Murphy, E., Darley-Usmar, V. M. and Gladwin, M. T. (2007) Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ. Res. 100, 654-661.